Serological response to a single dose of a SARS-CoV-2 mRNA vaccine

The delays in the production and delivery of COVID-19 vaccines and the growing number of fatal infections across the globe raised the question whether it would be more advantageous to vaccinate a larger group of individuals with one dose instead of a smaller one with two doses. Through a group of va...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Angélica, Cardoso, Maria João, Norton, Pedro, Sarmento, António, Guimarães, João Tiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252705/
https://www.ncbi.nlm.nih.gov/pubmed/34224753
http://dx.doi.org/10.1016/j.jviromet.2021.114223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252705/
https://www.ncbi.nlm.nih.gov/pubmed/34224753
http://dx.doi.org/10.1016/j.jviromet.2021.114223

Ejemplares similares